Concepedia

Annikka Kalliokoski

AK

Statistics

Publications

7

Citations

525

H-Index

7

Active since

2007

Affiliations

Helsinki University Hospital(Current)

University of Helsinki

Annikka Kalliokoski is an author at Helsinki University Hospital specializing in medicine, physiology, and metabolomics.

Top concepts

Publications per year

2007–2009

7

Publications

7

Different Effects of <i>SLCO1B1</i> Polymorphism on the Pharmacokinetics and Pharmacodynamics of Repaglinide and Nateglinide

Annikka Kalliokoski, Mikko Neuvonen, Pertti J. Neuvonen et al. · The Journal of Clinical Pharmacology · 2008 · 100 citations

, , +13

The Effect of Gemfibrozil on Repaglinide Pharmacokinetics Persists for at Least 12 h After the Dose: Evidence for Mechanism-based Inhibition of CYP2C8 In Vivo

Aleksi Tornio, Mikko Niemi, Mikko Neuvonen et al. · Clinical Pharmacology & Therapeutics · 2008 · 89 citations

Effects of Gemfibrozil and Atorvastatin on the Pharmacokinetics of Repaglinide in Relation to SLCO1B1 Polymorphism

Annikka Kalliokoski, KJ Kurkinen, Mikko Niemi · Clinical Pharmacology & Therapeutics · 2008 · 81 citations

Effects of the SLCO1B1*1B haplotype on the pharmacokinetics and pharmacodynamics of repaglinide and nateglinide

Annikka Kalliokoski, Janne T. Backman, Pertti J. Neuvonen et al. · Pharmacogenetics and Genomics · 2008 · 67 citations

The effect of <i>SLCO1B1</i> polymorphism on repaglinide pharmacokinetics persists over a wide dose range

Annikka Kalliokoski, Mikko Neuvonen, Pertti J. Neuvonen et al. · British Journal of Clinical Pharmacology · 2008 · 66 citations · Full text

1–5 of 7